Rose Marie Holman

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant

Sylvia Adams, David O’Neill, Daisuke Nonaka et al. · The Journal of Immunology · 2008 · 245 citations · Full text

Medicine, Immunology, Oncology +17

Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma

Rachel Lubong Sabado, Anna C. Pavlick, Sacha Gnjatic et al. · Cancer Immunology Research · 2015 · 91 citations · Full text

Medicine, Immunology, Oncology +17

Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Anna C. Pavlick, Ana-Belén Blázquez, Marcia Meseck et al. · Cancer Immunology Research · 2019 · 73 citations · Full text

Medicine, Immunology, Oncology +17

Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid–poly-l-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy

Elizabeth A. Miller, Meredith Spadaccia, Rachel Lubong Sabado et al. · Vaccine · 2014 · 10 citations

Life Sciences, Immunology, Infectious Diseases +17